ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | -25.0% | 530 | 0.0% | 0.00% | – |
| Q2 2023 | $4 | -20.0% | 530 | 0.0% | 0.00% | – |
| Q1 2023 | $5 | +25.0% | 530 | 0.0% | 0.00% | – |
| Q4 2022 | $4 | -99.9% | 530 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | 0.0% | 530 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -33.3% | 530 | +28.6% | 0.00% | – |
| Q1 2022 | $6,000 | -50.0% | 412 | 0.0% | 0.00% | – |
| Q4 2021 | $12,000 | -25.0% | 412 | -14.5% | 0.00% | – |
| Q3 2021 | $16,000 | +45.5% | 482 | +74.6% | 0.00% | – |
| Q2 2021 | $11,000 | 0.0% | 276 | 0.0% | 0.00% | – |
| Q1 2021 | $11,000 | -26.7% | 276 | +7.4% | 0.00% | – |
| Q4 2020 | $15,000 | -57.1% | 257 | -64.5% | 0.00% | – |
| Q3 2020 | $35,000 | +75.0% | 723 | +3.0% | 0.00% | – |
| Q2 2020 | $20,000 | 0.0% | 702 | 0.0% | 0.00% | – |
| Q1 2020 | $20,000 | -4.8% | 702 | 0.0% | 0.00% | – |
| Q4 2019 | $21,000 | – | 702 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |